Professor Hawking was presented with a sculpture of the genetic structure of Diethylcarbamazine
Professor Hawking said: “Collaboration between partners across the world over the last five years has accelerated us closer to the elimination of NTDs than ever before.”
NTDs are a group of infections that affect one in five people globally. They are most prevalent in developing countries causing severe and lifelong impairment. Frank Hawking was one of the first to research and develop a treatment for an Ntd known as lymphatic filariasis (Lf), which is still widely used today.
Professor Hawking said: “Throughout his career [my father] made some important discoveries. He believed in humanity and our ability to find solutions to the most pressing problems he witnessed.